404
+1-313-307-4176
HIV Diagnosis Market Report
Global HIV Diagnosis Market, By Product (Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software, Services), By Test Type (Antibody tests [HIV-1 screening tests {ELISA, Rapid Tests, Home Access Dried Blood Spot}], HIV-1 confirmatory tests {Western Blot Tests, Indirect Immune Fluorescent Antibody Assays (IFA), Line Immunoassays (LIA), Radio-Immunoprecipitation Assays (RIPA)}, HIV-2 & Group O diagnostic tests], Viral identification assays, CD4 testing, Viral load testing, Early infant diagnosis), By Application...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global HIV Diagnosis Market is projected to grow from USD 3.12 billion in 2020 to USD 5.28 billion by 2026 at a CAGR of over 9.2% during the forecast period
Figure: Global HIV Diagnosis Market Size, 2020-2026 (USD Billion)
Wish to get a free sample report? Click here.
Diagnosis of a blood sample to check the presence of HIV (Human Immunodeficiency Virus) in humans is regarded as HIV diagnosis.
The diagnosis of HIV helps to detect the presence of HIV that causes AIDS (Acquired Immunodeficiency Syndrome). This is carried by conducting tests on saliva, serum, or urine samples. These tests can detect antigens, antibodies, or RNA.
Key players operating in the global HIV diagnosis market are-
The growing prevalence of HIV/AIDS across the globe, significant technological developments, rising number of blood donations & blood transfusions that cause infections, rising government initiatives, and benefits offered by point-of-care instruments & kits are some of the key factors augmenting the market growth.
Moreover, recent advancements of simple rapid assays with visual testing coupled with easy handling home sample collection methods offer lucrative opportunities to the industry players. However, lack of mandates and high cost of Nucleic Acid Testing (NAT) in emerging countries are likely to hinder the market expansion.
Based on test type, the global HIV Diagnosis Market has been segmented into antibody tests, viral identification assays, CD4 testing, viral load testing, and early infant diagnosis.
By region, the North American market held the highest market share in 2020 and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to the presence of a technologically advanced healthcare framework, supportive reimbursement policies, and relatively higher healthcare expenditure in research and development, and the high prevalence of HIV thereby proliferates the industry growth in the region.
The COVID-19 pandemic has negatively affected the HIV diagnosis industry. Government bodies across the globe are focusing to curb the COVID-19 with important measures, such as nationwide lockdowns, social distancing, and large-scale quarantine to prevent the spread of the coronavirus. The number of tests conducted on whole blood donations, semen donations, and source plasma donations has been adversely impacted in 2020 due to COVID-19. For instance, the HIV tests market in the South plummeted to about 30% in 2020 due to the COVID-19 pandemic.
Get full Scope of the report. Register Here
The following is a list of the customers that the HIV Diagnosis market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The HIV Diagnosis Market is expected to witness an impressive growth of 9.2% CAGR in the foreseeable future.
Abbott (The U.S), Apogee Flow Systems Ltd. (UK), Atomo diagnostics (Australia), BD Biosciences (The U.S), Beckman Coulter Inc. (The U.S), BioMerieux SA (France), Cepheid (The U.S), ChemBio Diagnostics Inc. (The U.S), Daktari Diagnostics, Inc. (The U.S) and Hologic Inc. (The U.S) are among the key players in the HIV diagnosis market.
The HIV diagnosis market size is expected to reach USD 5.28 billion in the coming years.
North America held the largest share of HIV diagnosis market in 2020.
The antibody tests segment accounted for the largest share of HIV diagnosis market in 2020.
HIV diagnosis companies, HIV testing organizations, Hospitals, Biotech & pharma companies, Diagnostic Labs are the target audience in the HIV diagnosis market.
WE ACCEPT
